Live Breaking News & Updates on Euronext Nasdaq

Stay updated with breaking news from Euronext nasdaq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Celyad Oncology SA: Celyad Oncology to Host Virtual Research & Development Webinar on July 20th

Celyad Oncology SA: Celyad Oncology to Host Virtual Research & Development Webinar on July 20th
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Mont Saint Guibert , Waals Gewest , New York , United States , Walloon Region , France General , Sara Zelkovic , Exchange Commission , Communications Investor Relations , Lifesci Advisors , Research Development , Regulatory News , Euronext Nasdaq , Tuesday July , Celyad Oncology , Private Securities Litigation Reform Act , Annual Report , Media Contacts , Investor Relations Director , Sci Advisors , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , சுவர் பகுதி , பரிமாற்றம் தரகு , தகவல்தொடர்புகள் முதலீட்டாளர் உறவுகள் , ஆராய்ச்சி வளர்ச்சி ,

Celyad Oncology SA: Celyad Oncology to Participate at the William Blair Biotech Focus Conference 2021

Celyad Oncology SA: Celyad Oncology to Participate at the William Blair Biotech Focus Conference 2021
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Mont Saint Guibert , Waals Gewest , New York , United States , Walloon Region , France General , Sara Zelkovic , David Gilham , Exchange Commission , Communications Investor Relations , Lifesci Advisors , Regulatory News , Euronext Nasdaq , Chief Scientific Officer , William Blair Biotech Focus Conference , Private Securities Litigation Reform Act , Celyad Oncology , Annual Report , Media Contacts , Investor Relations Director , Sci Advisors , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , சுவர் பகுதி , டேவிட் கில்ஹாம் , பரிமாற்றம் தரகு ,

Celyad Oncology SA: Celyad: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Celyad Oncology SA: Celyad: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Mont Saint Guibert , Waals Gewest , New York , United States , Walloon Region , Lincoln Park , Sara Zelkovic , Filippo Petti , Lincoln Park Capital Fund , Exchange Commission , Communications Investor Relations , Lifesci Advisors , Regulatory News , Euronext Nasdaq , Open Market Sale , Belgian Law , Capital Increase , Chief Executive Officer , Private Securities Litigation Reform Act , Celyad Oncology , Annual Report , Media Contacts , Investor Relations Director , Sci Advisors , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் ,

Celyad Oncology SA: Celyad Oncology Announces June 2021 Conference Schedule

Celyad Oncology SA: Celyad Oncology Announces June 2021 Conference Schedule
Regulatory News:
Celyad Oncology SA (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (Euronext Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company plans to participate at the following conferences in June 2021:
Jefferies Virtual Healthcare Conference
Presentation date: Tuesday, June 1, 2021
Time: 11:00 a.m. EST 5:00 p.m. CET
Presenter: Filippo Petti, CEO
Events section of the Celyad Oncology website.
William Blair Company Annual Growth Stock Conference
Dates: Tuesday, June 1 Thursday, June 3, 2021
Presentation date: Wednesday, June 2, 2021 ....

Mont Saint Guibert , Waals Gewest , New York , United States , Walloon Region , France General , Sara Zelkovic , Filippo Petti , Exchange Commission , Communications Investor Relations , Lifesci Advisors , William Blair Company Annual Growth Stock Conference , Securities Life Sciences Conference , Regulatory News , Euronext Nasdaq , Virtual Healthcare Conference , Celyad Oncology , Blair Company Annual Growth Stock Conference , Life Sciences Conference , Cheuvreux Digital Life Science Day , Private Securities Litigation Reform Act , Annual Report , Media Contacts , Investor Relations Director , Sci Advisors , புதியது யார்க் ,

Celyad Oncology SA: Celyad Oncology to Present Data From Phase 1 IMMUNICY-1 Trial of Non-Gene Edited Allogeneic CAR T Candidate CYAD-211 in Relapsed/Refractory Multiple Myeloma at the European Hematology Association Virtual Congress

Celyad Oncology SA: Celyad Oncology to Present Data From Phase 1 IMMUNICY-1 Trial of Non-Gene Edited Allogeneic CAR T Candidate CYAD-211 in Relapsed/Refractory Multiple Myeloma at the European Hematology Association Virtual Congress
Initial clinical activity observed, with one confirmed partial response (PR) observed in this low dose (30x10
6 cells per infusion)
Regulatory News:
Celyad Oncology SA (Euronext Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T-cell (CAR T) therapies for cancer, today announced that an abstract highlighting initial clinical data from the Phase 1 IMMUNICY-1 trial of CYAD-211 has been accepted for e-poster presentation at the upcoming European Hematology Association (EHA) Virtual Congress 2021 ....

Mont Saint Guibert , Waals Gewest , New York , United States , Walloon Region , France General , Bruxelles Capitale , Region Flamande , Sara Zelkovic , Filippo Petti , Exchange Commission , Communications Investor Relations , Lifesci Advisors , Antwerp University Hospital , European Hematology Association , Virtual Congress , Euronext Nasdaq , Chief Executive Officer , Celyad Oncology , Poster Presentation Details , Scientific Publications , Private Securities Litigation Reform Act , Annual Report , Media Contacts , Investor Relations Director , Sci Advisors ,